APPOINTMENT OF MR SHAILENDRA PATHAK AS AN ADDITIONAL DIRECTOR SUBJECT TO APPROVAL OF SHAREHOLDERS
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Beryl Drugs Ltd has appointed Mr. Shailendra Pathak (age 60, diploma in electrical engineering, 40 years of experience) as an Additional Director on its board, to be regularised as a Whole Time Director subject to shareholder approval. In the same board meeting held on 3 January 2026, the company also appointed Mrs. Neha Sarda (age 42, CS and M.Com, 14 years of experience in finance and compliance) as an Independent Director (Non-Executive), also pending shareholder approval. Both appointments are recommended by the Nomination and Remuneration Committee and comply with SEBI LODR disclosure norms. Neither appointee is debarred from holding directorship by SEBI or any other authority.
These appointments strengthen the board with operational and compliance expertise. The addition of an Independent Director supports governance standards. For shareholders, the appointments are routine and unlikely to cause immediate stock price movement; investors should note that the Whole Time Director role for Mr. Pathak will only be confirmed after shareholder voting at the upcoming general meeting.